FDA Inspection 1133552 — Jeremy Ackermann, DO
The FDA completed an inspection of Jeremy Ackermann, DO on November 13, 2020 in North Charleston, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 13, 2020
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- North Charleston, SC (United States)
Additional Details
Clinical Investigator (CI)